[Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
Five patients hospitalized in the neonatal unit between 2002 and 2007, infected with vancomycin-resistant Enterococcus faecium treated with linezolid are presented in this study. This antibiotic showed good clinical efficacy and safety, since no adverse events occured in this group of patients.
Berberian
G
G
Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Combate de los Pozos 1881 (1245), Ciudad Autónoma de Buenos Aires, Argentina. griselberberian@yahoo.com.ar
Castro
G
G
Fistolera
S
S
Travaglianti
M
M
Lopardo
H
H
Mastroianni
A
A
Rosanova
M T
MT
D000081:Acetamides / Q000627:therapeutic use*; D001118:Argentina / Q000453:epidemiology; D015897:Comorbidity; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology; D016984:Enterococcus faecium / Q000187:drug effects* / Q000302:isolation & purification; D020345:Enterocolitis, Necrotizing / Q000453:epidemiology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000382:microbiology; D007363:Intensive Care Units, Neonatal; D000069349:Linezolid; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D023303:Oxazolidinones / Q000627:therapeutic use*; D010538:Peritonitis / Q000188:drug therapy / Q000453:epidemiology; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000382:microbiology; D020713:Vancomycin Resistance
D000081:Acetamides; D023303:Oxazolidinones; D000069349:Linezolid